Sanjay Goel MD , MS
Gastrointestinal Cancer, Clinical Pharmacology
Professor, Medicine, Rutgers Cancer Institute of New Jersey
Join to view full profile
165 Somerset StreetNew Brunswick, NJ 08901
Dr. Goel is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Albert Einstein College of MedicineM.S., Clinical Research Methodology, 2001 - 2003
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2000 - 2002- Albert Einstein College of MedicineFellowship, Hematology, Oncology, 2000 - 2002
University of ColoradoFellowship, Hematology and Medical Oncology, 1999 - 2000
University of Colorado Health Sciences CenterFellowship, Hematology, Oncology, 1999 - 2000
Certifications & Licensure
NY State Medical License 2002 - 2028
NJ State Medical License 2022 - 2027
VA State Medical License 2002 - 2008
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Translational Research Award ECOG Young Investigators Symposium, 2007
- Best Faculty Teaching 2005
- Best Presentation Glaxo Smith-Kline National Oncology Fellows Forum, 2002
Clinical Trials
Publications & Presentations
PubMed
- Activation of the endocytosis pathway stratifies subtypes and therapeutic sensitivity in colorectal cancer.Hiroyuki Arai, Andrew Elliott, Yan Yang, Alex Farrell, Joshua Millstein
Oncogene. 2026-10-19 - Participation of Patients With Gynecologic Cancer in Phase I Clinical Trials: Experience From Two National Cancer Institute-Designated Comprehensive Cancer Centers.Anusha Adkoli, Charlotte Hadjadj, Krystle Vera, Patrick Glennan, Viswanathan Shankar
JCO Oncology Practice. 2026-10-12 - Multikinase Inhibition with Tinengotinib in Advanced Solid Tumors: Results from a Multicenter Phase Ib/II Trial.Sarina A Piha-Paul, Chih-Yi Liao, Farshid Dayyani, Nashat Y Gabrail, Syed Mohammad Ali Kazmi
Clinical Cancer Research. 2026-07-23
Journal Articles
- Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case For Prophylaxis.Swami U, Goel S, Mani S, Curr Drug Targets, 4/15/2013
- Evolvement of the treatment paradigm for metastatic colon cancer. From chemotherapy to targeted therapy.Aparo S, Goel S, Crit Rev Oncol Hematol, 7/1/2012
- Eribulin-A review of preclinical and clinical studies.Swami U, Chaudhary I, Ghalib MH, Goel S, Crit Rev Oncol Hematol, 2/1/2012
Abstracts/Posters
- Tumor BiologyGoel S, 47th Annual Meeting of the American Society of Clinical Oncology, 6/1/2011
- “PIK3CA/PTEN mutation status predicts response of the colon cancer cells to the EGFR inhibitor cetuximab”Goel S, Jhawer M, Wilson AJ, et al, 2007 ECOG Young Investigators Symposium in Fort Lauderdale, FL, 1/1/2007
- Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamcis of Ixabepilone.Goel S, Goldberg G, Iacono L, et al, ASCO Annual Meeting Proceedings Part I, 6/20/2006
Lectures
- Assessing Response to Therapy: Radiographic Response Criteria Review2018 ASCO Annual Meeting - Chicago, Illinois - 06/5/2018
- Colorectal Cancer: Updates and Future DirectionsDepartment of Pathology, Assam Medical College, Dibrugah, Assam, India - 10/1/2010
- Updates in Colorectal CancerGrand Rounds, Department of Surgery, Montefiore Medical Center, Albert Einstein College of Medicine - 12/1/2006
Press Mentions
Why Phase 1 Trials Remain a Potential Viable Pathway for Pretreated Patients with Gynecologic CancersOctober 12th, 2026- Neil Palmisiano, MD, Appointed as Deputy Director of Phase 1 Therapeutics for Hematologic Malignancies at Rutgers Cancer Institute of New JerseyOctober 3rd, 2022
- Benefit of Biologic Agents in mCRC Is Color-BlindDecember 16th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
